Publications
- Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency2015 | First Faculty of Medicine
- Comparison of Two Prognostic Models in Patients with Metastatic Renal Cancer Treated with Sunitinib: a Retrospective, Registry-Based Study2015 | First Faculty of Medicine
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial2015 | Publication without faculty affiliation
- Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines2014 | First Faculty of Medicine, Second Faculty of Medicine
- Avastin in first-line treatment of metastatic breast cancer - our experiences: case report2013 | Second Faculty of Medicine
- Soft tissue sarcoma treatment from the perspective of new international guidelines2013 | Publication without faculty affiliation
- Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas2012 | First Faculty of Medicine, Second Faculty of Medicine
- Low Molecular Weight Heparins for Thromboprophylaxis during Induction Chemotherapy in Patients with Multiple Myeloma2011 | Publication without faculty affiliation
- Staging of non-Hodgkin's lymphoma - Recommendations of the Czech Lymphoma Study Group2010 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Kidney cancer. What is the next step after failure of treatment with angiogenesis inhibitors?2010 | Second Faculty of Medicine
Loading network view...